» Articles » PMID: 21242666

Polymorphisms of Hypoxia-related Genes in Subjects Susceptible to Acute Mountain Sickness

Overview
Journal Respiration
Publisher Karger
Specialty Pulmonary Medicine
Date 2011 Jan 19
PMID 21242666
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The occurrence of acute mountain sickness (AMS), which develops in some individuals who ascend to altitudes above 2,500 m, may be associated with 4 hypoxia-related genes (HIF-1, VEGFA, HSP-70 and eNOS).

Objectives: The aim of our study was to investigate the potential role of the 4 hypoxia-related genes in AMS pathogenesis. We therefore evaluated single-nucleotide polymorphisms (SNPs) of the genes in an association study using a case-control design.

Methods: At an altitude of 4,600 m, 64 male Chinese patients with AMS, defined according to the Lake Louise consensus criteria, were compared to 64 Chinese men free of symptoms of AMS. Clinical data, such as age, history of diseases, oxygen saturation (SpO(2)) and heart rate, were obtained. Genotypes of selected SNPs of these genes in patients were compared with those in controls.

Results: The mean SpO(2) and heart rate of the AMS and control groups were similar before ascent to high altitude (p = 0.79, p = 0.62) but, 24 h after ascent, the mean SpO(2) of the AMS group was significantly lower than that of the control group (p = 0.001), and the mean heart rate of the AMS group was significantly higher than that of the control group (p = 0.001). Twenty-eight of the 48 SNPs investigated were successfully genotyped, and SNP allele frequencies were obtained. The rs3025039 SNP and the haplotype (rs1413711, rs833070 and rs3025000) in the VEGFA gene were significantly associated with AMS (p = 0.0435 and 0.024, respectively).

Conclusions: Our study demonstrates a possible association between the VEGFA gene and AMS. We conclude that VEGFA may have an important role in the AMS process.

Citing Articles

The role of hypoxia related hormones responses in acute mountain sickness susceptibility individuals unaccustomed to high altitude.

Fayazi B, Tadibi V, Ranjbar K PLoS One. 2023; 18(10):e0292173.

PMID: 37796960 PMC: 10553285. DOI: 10.1371/journal.pone.0292173.


Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness.

Nourkami-Tutdibi N, Kullmer J, Dietrich S, Monz D, Zemlin M, Tutdibi E Front Physiol. 2023; 14:1083808.

PMID: 37064896 PMC: 10098311. DOI: 10.3389/fphys.2023.1083808.


Establishing a prediction model of severe acute mountain sickness using machine learning of support vector machine recursive feature elimination.

Yang M, Wu Y, Yang X, Liu T, Zhang Y, Zhuo Y Sci Rep. 2023; 13(1):4633.

PMID: 36944699 PMC: 10030784. DOI: 10.1038/s41598-023-31797-0.


Acute Mountain Sickness Following Incremental Trekking to High Altitude: Correlation With Plasma Vascular Endothelial Growth Factor Levels and the Possible Effects of Dexamethasone and Acclimatization Following Re-exposure.

Winter C, Bjorkman T, Miller S, Nichols P, Cardinal J, ORourke P Front Physiol. 2021; 12:746044.

PMID: 34744786 PMC: 8567072. DOI: 10.3389/fphys.2021.746044.


HSPA1A gene polymorphism rs1008438 is associated with susceptibility to acute mountain sickness in Han Chinese individuals.

Liu Z, Chen H, Xu T, Wang X, Yao C Mol Genet Genomic Med. 2020; 8(8):e1322.

PMID: 32478477 PMC: 7434611. DOI: 10.1002/mgg3.1322.